DSC8357 cropDeveloping State-of-the-Art Technology for Drug Discovery:

The BCDD's facilities offer a breadth of capabilities and technologies, which support diverse and collaborative research activities to promote the discovery and development of new therapeutics at TAU. Several novel approaches are being used for biological target identification and compound validation processes such as high throughput image-based screening analysis together with complementary high throughput genomics, metabolomics and proteomics. Additionally, the computational chemistry lab uses the most advanced computational tools to design the optimal compounds for the in-house synthesis of small molecules and peptides is provided by the medicinal chemistry lab.